Picture of Veracyte logo

VCYT Veracyte Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Veracyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-12.6-34.9-75.6-36.6-74.4
Depreciation
Deferred Taxes
Non-Cash Items10.117.726.434.499.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital-4.85-0.4814.22-16.4-4.16
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-3.23-9.71-31.67.5444.2
Capital Expenditures-2.76-2.84-5.38-8.55-9.96
Purchase of Fixed Assets
Other Investing Cash Flow Items-40-1-734-20.825.1
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-42.7-3.84-739-29.415.1
Financing Cash Flow Items0-3.85-9.03-3.17-6.74
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1272045963.492.84
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash81.3190-176-18.962.3